Adrenergic and dopaminergic agents
Droxidopa
The FDA lists this product in 48 strengths and forms.
Composition
- Active ingredients
- DROXIDOPA 300MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DROXIDOPA 200MG · CapsuleANDA211818-002 · Prescription
- DROXIDOPA 300MG · CapsuleANDA211818-003 · Prescription
- DROXIDOPA 100MG · CapsuleANDA211818-001 · Prescription
- DROXIDOPA 200MG · CapsuleANDA213162-002 · Discontinued
- DROXIDOPA 300MG · CapsuleThis page
- DROXIDOPA 100MG · CapsuleANDA213162-001 · Discontinued
- DROXIDOPA 200MG · CapsuleANDA215265-002 · Prescription
- DROXIDOPA 300MG · CapsuleANDA215265-003 · Prescription
- DROXIDOPA 100MG · CapsuleANDA215265-001 · Prescription
- DROXIDOPA 300MG · CapsuleANDA213661-003 · Discontinued
- DROXIDOPA 100MG · CapsuleANDA213661-001 · Discontinued
- DROXIDOPA 200MG · CapsuleANDA213661-002 · Discontinued
- DROXIDOPA 300MG · CapsuleANDA214387-003 · Prescription
- DROXIDOPA 100MG · CapsuleANDA214387-001 · Prescription
At a glance
- Brand name
- Droxidopa
- Drug class
- Adrenergic and dopaminergic agents
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Teva Pharms USA Inc
- Status
- Discontinued
- FDA approval
- 18 Feb 2021
- Application
- ANDA213162-003
- RxCUI
- 1489913